Richard Bernstein Advisors’s Allergan plc AGN Stock Holding History

Richard Bernstein Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,004	Closed	-$2.93M	–	277
2019 Q1	$2.93M	Hold	20,004	–	–	0.1%	182
2018 Q4	$2.67M	Buy	20,004 +3,191	+19%	+$523K	0.1%	211
2018 Q3	$3.2M	Buy	+16,813	New	+$3.09M	0.09%	240
2016 Q1	–	Sell	-20,698	Closed	-$6.47M	–	279
2015 Q4	$6.47M	Hold	20,698	–	–	0.83%	33
2015 Q3	$5.63M	Hold	20,698	–	–	0.77%	40
2015 Q2	$6.28M	Hold	20,698	–	–	0.76%	37
2015 Q1	$6.16M	Hold	20,698	–	–	0.81%	37
2014 Q4	$5.33M	Hold	20,698	–	–	0.55%	67
2014 Q3	$4.99M	Hold	20,698	–	–	0.53%	68
2014 Q2	$4.62M	Hold	20,698	–	–	0.54%	68
2014 Q1	$4.26M	Buy	20,698 +4,945	+31%	+$980K	0.6%	62
2013 Q4	$2.65M	Buy	15,753 +1,312	+9%	+$205K	0.54%	47
2013 Q3	$2.08M	Hold	14,441	–	–	0.61%	35
2013 Q2	$1.82M	Buy	+14,441	New	+$1.64M	0.6%	35

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Richard Bernstein Advisors's AGN Position: Q2 2019 in Review

Richard Bernstein Advisors sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 20,004 shares — an estimated $2.93M sold.

Richard Bernstein Advisors first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $6.47M in Q4 2015. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Richard Bernstein Advisors reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Richard Bernstein Advisors sold 20,004 Allergan plc shares in Q2 2019, an estimated $2.93M.
Richard Bernstein Advisors first reported a position in Allergan plc in Q2 2013 and held it in 14 quarters.
Richard Bernstein Advisors's Allergan plc position peaked at $6.47M in Q4 2015.
970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Richard Bernstein Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.